Tominaga, Naoto http://orcid.org/0000-0002-3699-7418
Kida, Keisuke
Inomata, Takayuki
Sato, Naoki
Izumi, Tohru
Akashi, Yoshihiro J.
Shibagaki, Yugo
Funding for this research was provided by:
The Kidney Foundation, Japan
Article History
Received: 28 October 2017
Accepted: 12 June 2018
First Online: 22 June 2018
Compliance with ethical standards
:
: Naoto Tominaga, Takayuki Inomata, Naoki Sato, and Yugo Shibagaki received lecture fees from Otsuka Pharmaceutical Co., Ltd. Yugo Shibagaki received research grants from Otsuka Pharmaceutical Co., Ltd.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee at which the studies were conducted (IRB approval number 2301) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: The original trial of this subanalysis [The Kanagawa Aquaresis Investigators Trial of TLV on Heart Failure (HF) Patients with Renal Impairment (K-STAR)] was registered with the University Hospital Medical Information Network (UMIN ID 000009201).
: Informed consent was obtained from all individual participants included in the study.